Volume | 20,168 |
|
|||||
News | - | ||||||
Day High | 2.30 | Low High |
|||||
Day Low | 2.21 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Check Cap Ltd | CHEK | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
2.26 | 2.21 | 2.30 | 2.26 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
55 | 20,168 | US$ 2.27 | US$ 45,726 | - | 1.27 - 4.625 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
11:48:20 | 18 | US$ 2.27 | USD |
Check Cap Ltd Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
13.22M | 5.85M | - | 0 | -19.11M | -3.27 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Check Cap News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CHEK Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 2.35 | 2.41 | 2.12 | 2.23 | 30,833 | -0.09 | -3.83% |
1 Month | 2.00 | 3.45 | 1.95 | 2.50 | 790,458 | 0.26 | 13.00% |
3 Months | 2.13 | 3.45 | 1.78 | 2.48 | 270,896 | 0.13 | 6.10% |
6 Months | 3.32 | 3.937 | 1.78 | 2.50 | 137,512 | -1.06 | -31.93% |
1 Year | 1.31 | 4.625 | 1.27 | 2.64 | 112,151 | 0.95 | 72.52% |
3 Years | 29.60 | 38.178 | 1.22 | 17.75 | 720,129 | -27.34 | -92.36% |
5 Years | 51.20 | 89.80 | 1.22 | 29.59 | 2,234,622 | -48.94 | -95.59% |
Check Cap Description
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. |